Prime Medicine PRME Trading assets
Trading assets at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue.
The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prime Medicine's trading assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Prime Medicine's trading assets?
- Prime Medicine (PRME) reported trading assets of $71.39M in Q1 2026.
- How has Prime Medicine's trading assets changed year-over-year?
- Prime Medicine's trading assets increased by 47.3% year-over-year, from $48.47M to $71.39M.
- What is the long-term trend for Prime Medicine's trading assets?
- Over 4 years (2021 to 2025), Prime Medicine's trading assets has grown at a 13.9% compound annual growth rate (CAGR), from $68.24M to $114.65M.
- What does trading assets mean?
- Securities and other financial instruments held for short-term trading purposes, measured at fair value with changes flowing through the income statement.